Overall, these results suggest that FILIP1L is downregulated (at least in part) by promoter methylation, which is associated with heavy smoking in patients with LUAD, and that FILIP1L downregulation is associated with a more aggressive (less differentiated) tumor histology. Here, FILIP1L is linked to neoplasm.